Takeda Pharmaceutical Dividend
Dividend criteria checks 3/6
Takeda Pharmaceutical is a dividend paying company with a current yield of 4.53%.
Key information
4.5%
Dividend yield
161%
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | US$113.59 |
Dividend yield forecast in 3Y | 4.7% |
Recent dividend updates
Recent updates
Takeda Pharmaceutical Company: Attractive Stock But Needs To Grow Net Profits
Mar 03Takeda: Why I'm Staying Bearish On This Generic Drug Dividend Play
Oct 24Takeda: Innovative But Volatile, Fairly Priced For The Risk (Downgrade)
Aug 31Takeda: Upside Case Strengthening, Looking To 15x Earnings
Jun 21Takeda Pharmaceutical Q3 Earnings Preview
Feb 01Takeda's Exkivity gets approval in China for lung cancer subtype
Jan 11Takeda: Late-Stage Pipeline Catalysts Approaching, But Vyvanse Patent Expiration Looms
Dec 13Takeda: Momentum Building Around Core Offerings, Rate Buy
Dec 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: TAK's dividends per share have been stable in the past 10 years.
Growing Dividend: TAK's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Takeda Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (TAK) | 4.5% |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (TAK) | 4.7% |
Notable Dividend: TAK's dividend (4.53%) is higher than the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: TAK's dividend (4.53%) is low compared to the top 25% of dividend payers in the US market (4.74%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (161.2%), TAK's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: TAK is paying a dividend but the company has no free cash flows.